Jim Musick

Jim Musick

Company: Vitro Biopharma

Job title: CSO and Director

Seminars:

Industry Leader’s Fireside Chat: Discussing the Scope & Landscape of Cell Therapy for Neurological Disease 8:45 am

How can we use the successes and lessons learned from cell therapies in oncology to inform and improve treatments for neurological diseases? Outlining the progress in this space and spotlighting achievements from leading companies in the field Reaffirming the importance and relevance for cell therapies for neurological disorders in comparison to other treatment modalitiesRead more

day: Conference Day One

Examining Future Potential Indications of Cell Therapies for Neurological Disorders 3:00 pm

Discovering the next potential neurological indications where cell therapies could be utilized in neurological disorders such as pain, autism, etc Reviewing the literature to understand how efficacious cell therapies could be in these areas Unravelling the challenges associated with these different indicationsRead more

day: Conference Day Two

Panel Discussion: Exploring the ‘Low Hanging Fruit’ Indications & Choosing Specific Target Indications 3:30 pm

Which indications are expected to be the first to accelerate through the clinic? Which indications have the most funding associated with them?Read more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.